Resona Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Resona Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$40.3M	Buy	90,312 +913	+1%	+$426K	0.2%	99
2025 Q4	$40.6M	Sell	89,399 -2,699	-3%	-$1.16M	0.2%	96
2025 Q3	$36.1M	Sell	92,098 -4,351	-5%	-$1.82M	0.17%	114
2025 Q2	$42.9M	Buy	96,449 +5,687	+6%	+$2.62M	0.21%	99
2025 Q1	$44.1M	Buy	90,762 +4,535	+5%	+$2.11M	0.26%	81
2024 Q4	$34.8M	Sell	86,227 -7,976	-8%	-$3.7M	0.21%	95
2024 Q3	$43.8M	Sell	94,203 -2,475	-3%	-$1.19M	0.25%	78
2024 Q2	$45.4M	Sell	96,678 -4,803	-5%	-$2.08M	0.27%	68
2024 Q1	$42.4M	Buy	+101,481	New	+$42.9M	0.25%	81

Other funds holding VRTX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Resona Asset Management's VRTX Position: Q1 2026 in Review

Resona Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 1% in Q1 2026, buying an estimated $426K and bringing the position to 90,312 shares worth $40.3M. The position accounts for 0.2% of the portfolio, ranked #99.

Resona Asset Management first reported a position in VRTX in Q1 2024 and has held it in 9 quarters since. The position peaked at $45.4M in Q2 2024. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

Resona Asset Management held 90,312 shares of Vertex Pharmaceuticals worth $40.3M as of Q1 2026.
Resona Asset Management bought 913 Vertex Pharmaceuticals shares in Q1 2026, an estimated $426K.
Vertex Pharmaceuticals made up 0.2% of Resona Asset Management's portfolio in Q1 2026, its #99 holding.
Resona Asset Management first reported a position in Vertex Pharmaceuticals in Q1 2024 and has held it in 9 quarters since.
Resona Asset Management's Vertex Pharmaceuticals position peaked at $45.4M in Q2 2024.
1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Resona Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.